CN106924173A - 一种药物负载介孔材料及其制备方法 - Google Patents
一种药物负载介孔材料及其制备方法 Download PDFInfo
- Publication number
- CN106924173A CN106924173A CN201710215848.XA CN201710215848A CN106924173A CN 106924173 A CN106924173 A CN 106924173A CN 201710215848 A CN201710215848 A CN 201710215848A CN 106924173 A CN106924173 A CN 106924173A
- Authority
- CN
- China
- Prior art keywords
- mesoporous material
- pla
- drug loading
- shitosan
- crude product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013335 mesoporous material Substances 0.000 title claims abstract description 69
- 239000003814 drug Substances 0.000 title claims abstract description 55
- 229940079593 drug Drugs 0.000 title claims abstract description 40
- 238000011068 loading method Methods 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 66
- 239000002608 ionic liquid Substances 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 239000012043 crude product Substances 0.000 claims description 39
- 239000000243 solution Substances 0.000 claims description 24
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 22
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 16
- 238000001556 precipitation Methods 0.000 claims description 14
- 208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 11
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 238000004108 freeze drying Methods 0.000 claims description 8
- 238000009833 condensation Methods 0.000 claims description 7
- 230000005494 condensation Effects 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 7
- 238000007710 freezing Methods 0.000 claims description 7
- 230000008014 freezing Effects 0.000 claims description 7
- 239000011261 inert gas Substances 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 2
- 239000000047 product Substances 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 claims 1
- 235000019441 ethanol Nutrition 0.000 claims 1
- 238000007654 immersion Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000013268 sustained release Methods 0.000 abstract description 3
- 239000012730 sustained-release form Substances 0.000 abstract description 3
- 239000004626 polylactic acid Substances 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 6
- 150000003851 azoles Chemical class 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229920001661 Chitosan Polymers 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000000599 controlled substance Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 244000060696 Alpinia speciosa Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000002336 sorption--desorption measurement Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710215848.XA CN106924173B (zh) | 2017-03-29 | 2017-03-29 | 一种药物负载介孔材料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710215848.XA CN106924173B (zh) | 2017-03-29 | 2017-03-29 | 一种药物负载介孔材料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106924173A true CN106924173A (zh) | 2017-07-07 |
CN106924173B CN106924173B (zh) | 2020-11-06 |
Family
ID=59425831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710215848.XA Expired - Fee Related CN106924173B (zh) | 2017-03-29 | 2017-03-29 | 一种药物负载介孔材料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106924173B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1476907A (zh) * | 2003-06-30 | 2004-02-25 | 暨南大学 | 生物活性三维多孔组织工程支架材料及其制备方法 |
CN1958081A (zh) * | 2006-10-23 | 2007-05-09 | 天津大学 | 壳聚糖-聚乳酸共聚物三维多孔支架制备方法 |
CN102321271A (zh) * | 2011-09-15 | 2012-01-18 | 西安交通大学 | 一种生物活性壳聚糖基多孔支架的制备方法 |
CN105017541A (zh) * | 2015-07-09 | 2015-11-04 | 广西师范学院 | 香蕉纤维素微晶/聚乳酸气凝胶及其制备方法和用途 |
-
2017
- 2017-03-29 CN CN201710215848.XA patent/CN106924173B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1476907A (zh) * | 2003-06-30 | 2004-02-25 | 暨南大学 | 生物活性三维多孔组织工程支架材料及其制备方法 |
CN1958081A (zh) * | 2006-10-23 | 2007-05-09 | 天津大学 | 壳聚糖-聚乳酸共聚物三维多孔支架制备方法 |
CN102321271A (zh) * | 2011-09-15 | 2012-01-18 | 西安交通大学 | 一种生物活性壳聚糖基多孔支架的制备方法 |
CN105017541A (zh) * | 2015-07-09 | 2015-11-04 | 广西师范学院 | 香蕉纤维素微晶/聚乳酸气凝胶及其制备方法和用途 |
Non-Patent Citations (3)
Title |
---|
朱庆松 等: "壳聚糖在4 种咪唑型离子液体中溶解性的研究", 《高分子学报》 * |
梅兴国: "《微载体药物递送系统》", 30 November 2009, 华中科技大学出版社 * |
黄天辉 等: "乳液冷冻干燥法制备壳聚糖/聚乳酸复合材料", 《北京航空航天大学学报》 * |
Also Published As
Publication number | Publication date |
---|---|
CN106924173B (zh) | 2020-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Qureshi et al. | Carrageenan: A wonder polymer from marine algae for potential drug delivery applications | |
CN102399295B (zh) | 低巯基化改性度生物相容高分子巯基化衍生物及其交联材料和用途 | |
US9220676B2 (en) | Injectable in-situ crosslinked hydrogel and methods of making and using thereof | |
LU500813B1 (en) | Asiaticoside-chitosan-sodium Alginate Microsphere and Preparation Method and Application thereof | |
US20190054015A1 (en) | Temperature sensitive hydrogel composition including nucleic acid and chitosan | |
WO2014005471A1 (zh) | 一种温敏型可注射壳聚糖水凝胶产品及其应用 | |
CN102727930A (zh) | 一种医用可吸收骨创面止血材料及其制备方法 | |
EP3865156B1 (en) | Sustained-release injection formulation comprising conjugate of poly-l-lactic acid filler and hyaluronic acid filler and bioactive materials, and preparation method thereof | |
KR20110127746A (ko) | 주사용 바이오물질 | |
Zheng et al. | A novel pullulan oxidation approach to preparing a shape memory sponge with rapid reaction capability for massive hemorrhage | |
CN113429589B (zh) | 甘草酸基pH敏感型缓释水凝胶材料及其制备方法与应用 | |
Sun et al. | Thermo-responsive hydroxybutyl chitosan hydrogel as artery intervention embolic agent for hemorrhage control | |
Aziz et al. | Preparation of electrospun nanofibers based on wheat gluten containing azathioprine for biomedical application | |
CN109627463A (zh) | 水凝胶与蛋白质药物 | |
CN111388755A (zh) | 一种可注射型透明质酸/壳聚糖水凝胶及其制备方法 | |
CN101148520A (zh) | 一种温度敏感的壳聚糖水凝胶 | |
CN105148322B (zh) | 可注射水凝胶及其制备方法 | |
CN107708722A (zh) | 慢性伤口治疗用组合物、其制备方法和利用其的慢性伤口治疗用敷料 | |
Ilomuanya | Hydrogels as biodegradable biopolymer formulations | |
CN107722304A (zh) | 触变氧化纤维素溶液及其医疗应用 | |
CN109232995A (zh) | 可以调节响应温度的温敏性水凝胶包载细胞材料及其制备方法与应用 | |
CN108404207A (zh) | 温敏壳聚糖水凝胶细胞因子复合支架的制备方法 | |
Shahriari et al. | Advances in self-healing hydrogels to repair tissue defects | |
CN106924173A (zh) | 一种药物负载介孔材料及其制备方法 | |
CN115671405B (zh) | 一种关节腔注射凝胶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230208 Address after: 073000 West 200m northbound at the intersection of Dingzhou commercial street and Xingding Road, Baoding City, Hebei Province (No. 1910, 19th floor, building 3, jueshishan community) Patentee after: Hebei Kaitong Information Technology Service Co.,Ltd. Address before: 530200 No.8, Longting Road, Yongning District, Nanning City, Guangxi Zhuang Autonomous Region Patentee before: NANNING University Effective date of registration: 20230208 Address after: 261300 No. 46, Dawang Village, Puzhuang Town, Changyi City, Weifang City, Shandong Province Patentee after: Wang Xiwei Address before: 073000 West 200m northbound at the intersection of Dingzhou commercial street and Xingding Road, Baoding City, Hebei Province (No. 1910, 19th floor, building 3, jueshishan community) Patentee before: Hebei Kaitong Information Technology Service Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230606 Address after: 323-2, Building 1, North of East Guihua Road, Gaoxin Second Road, Weifang Comprehensive Free Trade Zone, Shandong 261000 Patentee after: Weifang Tuoyun Biotechnology Co.,Ltd. Address before: 261300 No. 46, Dawang Village, Puzhuang Town, Changyi City, Weifang City, Shandong Province Patentee before: Wang Xiwei |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20201106 |